Neurorescue by a ROS Decomposition Catalyst

ACS Chem Neurosci. 2016 Oct 19;7(10):1374-1382. doi: 10.1021/acschemneuro.6b00144. Epub 2016 Aug 5.

Abstract

The effect of the bis-sulfonated iron(III) corrole (1-Fe), a potent decomposition catalyst of reactive oxygen species, on rescuing SN4741 cells that were damaged by 6-hydroxydopamine (6-OHDA) was investigated as an in vitro model system for studying cell death of dopaminergic neurons in the substantia nigra. Important findings that accompanied the ability to rescue dopaminergic neurons were increased expression of phenotypic dopaminergic proteins, such as tyrosine hydroxylase (TH) and dopamine transporter (DAT), which were significantly depleted upon 6-OHDA-mediated damage. 1-Fe also elevated expression levels of aldehyde dehydrogenase 1 (ALDH-1), previously disclosed as a cardinal protein in the pathogenesis of Parkinson's disease. Since these findings suggested that 1-Fe affects quite a wide range of intracellular mechanisms, vital intracellular pathways that involve neuroplasticity, growth, differentiation and survival of neurons, were examined. Phosphatidylinositol 3-kinase (PI3K) and protein kinase c (PKC) were found to be involved, as pharmacological inhibitors of these kinases abolished the neurorescue effect of 1-Fe. 1-Fe also elevated the expression of antiapoptotic protein Bcl-2, which is essential for proper mitochondrial function and cellular survival. The overall conclusion is that 1-Fe is capable of rescuing already damaged neuronal cells by a variety of mechanisms that are beyond its antioxidant activity.

Keywords: Parkinson’s disease; catalytic antioxidants; neurodegeneration; neurorescue; redox signaling.

MeSH terms

  • Aldehyde Dehydrogenase 1 Family
  • Animals
  • Antioxidants / pharmacology*
  • Cell Line
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Dopaminergic Neurons / drug effects*
  • Dopaminergic Neurons / metabolism
  • Dopaminergic Neurons / pathology
  • Drug Evaluation, Preclinical
  • Enzyme Inhibitors / pharmacology
  • Isoenzymes / metabolism
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Metalloporphyrins / pharmacology*
  • Mice
  • Neuroprotective Agents / pharmacology*
  • Oxidopamine / toxicity
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Reactive Oxygen Species / metabolism
  • Retinal Dehydrogenase / metabolism
  • Tyrosine 3-Monooxygenase / metabolism

Substances

  • 2,17-bis-sulfonato-5,10,15-tris(pentafluorophenyl)corrolatoiron(III)
  • Antioxidants
  • Dopamine Plasma Membrane Transport Proteins
  • Enzyme Inhibitors
  • Isoenzymes
  • Metalloporphyrins
  • Neuroprotective Agents
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Reactive Oxygen Species
  • Bcl2 protein, mouse
  • Oxidopamine
  • Tyrosine 3-Monooxygenase
  • Aldehyde Dehydrogenase 1 Family
  • ALDH1A1 protein, mouse
  • Retinal Dehydrogenase
  • Protein Kinase C